Sandoz Group AG

Common Name
Sandoz Group
Country
Switzerland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
20,000
Ticker
SDZ
Exchange
SIX SWISS EXCHANGE
Description
Sandoz Group AG is a global leader in the pharmaceuticals industry, specializing in the development and manufacture of generic drugs and biosimilars. The company, part of the Novartis Group until its ...

Financial Statements of Sandoz Group

Below are the financial statements of Sandoz Group, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD20242023
Net sales to third parties
10,357a
9,647a
Sales to former parent
0a
302a
Net sales
10,357a
9,949a
Other revenues
27a
30a
Cost of goods sold
-5,458a
-5,415a
Gross profit
4,926a
4,564a
Selling, general and administration
-2,433a
-2,389a
Development and regulatory
-932a
-926a
Other income
215a
94a
Other expense
-1,469a
-968a
Operating income
307a
375a
Interest expense
-251a
-202a
Other financial income and expense
-67a
-43a
(Loss)/ income before taxes
-11a
130a
Income taxes
-12a
-50a
Net income
1a
80a
Attributable to
Shareholders of Sandoz Group AG
0a
77a
Non-controlling interests
1a
3a
Download Data

Verified Sources Behind Sandoz Group’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sandoz Group’s data sources below and access millions more through our Disclosure Search.

a. Sandoz Group's Integrated Report 2024
a. Sandoz Group's Integrated Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?